Before catheter ablation or pacemaker implantation, all patients in both groups actually met the criteria for permanent pacing due to symptomatic prolonged sinus pauses on termination of AF (Fig. 2), ...
Cardiology experts highlight growing incidence of Bradycardia, need for early diagnosis and intervention: Our Bureau, Mumbai Monday, March 2, 2026, 17:25 Hrs [IST] Leading cardiol ...
Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...
(HealthDay News) — The world’s smallest pacemaker is safe and effective in patients with symptomatic bradycardia, according to the first human clinical trial of the device. The findings were presented ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A leadless pacing-defibrillator system was safe and met ...
Drug induced bradycardia is an important but poorly characterized common clinical problem. This is reflected by the absence of definitions of various clinical forms of drug induced bradycardia in the ...
World’s First Leadless Left Bundle Branch Area Pacing Implant Utilizing EBR Systems’ WiSE CRT System
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that Professor Pascal Defaye, Head of Rhythmology ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced the publication of a case report demonstrating ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Left bundle ...
Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new research published today in Circulation ...
Please provide your email address to receive an email when new articles are posted on . The FDA has identified Abbott’s recall of two scalable bradycardia platform pacemakers as Class I, the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results